Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Company research

Jin Medical International Ltd.

CIK 1837821Updated Nov 2, 2026

ZJYL price & chart

Provider market data

Loading TradingView…

NASDAQ:ZJYL on TradingView ↗

TradingView · Data may be delayed

About the company

Founded in 2006 and headquartered at Changzhou, Jiangsu Province of China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderly individuals, and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with 430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China. Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please visit: http://www.jinmed.com.

6-K · 2026-08-04 · 0001213900-26-085283

Company description from the cited filing.

In the news

No coverage from other publishers is available.

Seeking Alpha

Recent filings

  1. F-3ASR filing

    F-3ASR · 2026-11-20 · 0001213900-26-122791

  2. 6-K filing

    6-K · 2026-10-30 · 0001213900-26-114281

  3. 6-K filing

    6-K · 2026-09-24 · 0001213900-26-103071

  4. 6-K filing

    6-K · 2026-09-08 · 0001213900-26-098090

  5. SCHEDULE 13G - filed by NOVASTRALIST HORIZON LTD regarding Jin Medical International Ltd.

    SCHEDULE 13G · 2026-08-18 · 0001185185-26-003602

Show 5 more recent filings
  1. 6-K filing

    6-K · 2026-08-04 · 0001213900-26-085283

  2. 6-K filing

    6-K · 2026-07-20 · 0001213900-26-079674

  3. 6-K filing

    6-K · 2026-07-15 · 0001213900-26-078342

  4. 6-K/A filing

    6-K/A · 2026-06-30 · 0001213900-26-073727

  5. 6-K filing

    6-K · 2026-06-29 · 0001213900-26-073135

Financials

FY 2025 · USD
Revenue20,687,274USD · FY 2025
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

Net income1,191,297USD · FY 2025
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

Cash— · FY 2025
Operating income608,182USD · FY 2025
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

Diluted EPS0.01USD per share · FY 2025
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemQ2 2025Q2 2024Q2 2023FY 2025FY 2024FY 2023
ASSETS
AssetsUSD48,523,494
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

41,160,123
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

31,022,497
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

53,368,358
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

45,800,769
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

32,903,450
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Property, Plant and Equipment, NetUSD3,337,796
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

1,464,107
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

1,582,650
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

7,895,385
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

1,460,286
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

1,480,796
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Current assets:
Accounts Receivable, after Allowance for Credit Loss, CurrentUSD4,238,724
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

3,856,529
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

291,883
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

5,807,386
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

5,912,035
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

3,283,266
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Inventory, NetUSD4,455,065
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

4,540,852
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

6,509,349
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

4,923,164
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

5,173,458
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

5,053,136
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Assets, CurrentUSD43,780,955
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

38,177,840
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

29,089,100
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

44,143,213
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

42,816,216
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

31,115,815
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Prepaid Expense and Other Assets, CurrentUSD2,607,496
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

2,202,847
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

163,356
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

3,676,136
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

2,325,029
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

892,597
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Operating Lease, Right-of-Use AssetUSD175,803
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

263,331
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

166,476
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

85,157
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

256,117
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

154,364
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

LIABILITIES AND EQUITY
LiabilitiesUSD20,767,173
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

15,005,210
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

7,475,978
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

23,795,891
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

17,248,309
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

8,924,345
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Stockholders’ equity:
Common Stock, Value, IssuedUSD7,827
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

7,827
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

7,750
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

7,827
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

7,827
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

7,797
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Additional Paid in CapitalUSD6,749,144
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

6,749,144
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

6,053,131
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

—6,749,144
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

6,437,179
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Retained Earnings (Accumulated Deficit)USD19,860,865
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

18,455,159
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

15,998,640
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

20,940,978
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

20,021,346
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

16,927,605
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Accumulated Other Comprehensive Income (Loss), Net of TaxUSD-1,369,835
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

-1,245,394
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

-340,974
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

-923,968
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

-556,209
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

-1,404,366
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Stockholders' Equity Attributable to ParentUSD27,912,550
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

26,244,166
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

23,546,519
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

29,638,722
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

28,815,184
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

23,979,105
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Additional Paid in Capital, Common StockUSD———6,749,144
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

——
Liabilities and EquityUSD48,523,494
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

41,160,123
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

31,022,497
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

53,368,358
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

45,800,769
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

32,903,450
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Current liabilities:
Liabilities, CurrentUSD20,737,078
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

14,825,519
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

7,475,978
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

23,795,891
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

17,152,134
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

8,924,345
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Operating Lease, Liability, CurrentUSD159,420
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

88,297
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

—72,645
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

185,154
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

—
Accounts Payable, CurrentUSD3,056,059
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

3,146,451
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

4,614,084
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

3,256,624
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

3,012,334
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

3,391,079
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Operating Lease, Liability, NoncurrentUSD30,095
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

179,691
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

——96,175
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

—
Stockholders' Equity Attributable to Noncontrolling InterestUSD-156,229
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

-89,253
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

—-66,255
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

-262,724
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

—
Additional Financial Items
Accounts Receivable, after Allowance for Credit LossUSD—3,200,000
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

3,869,399
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

——3,283,266
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Short-term InvestmentsUSD19,824,675
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

17,113,103
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2024-03-31

4,696,503
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

22,168,607
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

18,621,251
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

9,768,835
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Cash and Cash Equivalents, at Carrying Value———
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

———
Deferred Revenue, Current———
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2023-03-31

———

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemQ2 2025Q2 2024Q2 2023Q2 2022FY 2025FY 2024FY 2023
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD————1,381,245
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,419,835
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, Depletion and AmortizationUSD————243,403
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

237,823
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

225,902
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Changes in operating assets and liabilities:
Increase (Decrease) in Accounts ReceivableUSD————-1,284,554
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

2,386,501
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-348,730
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Increase (Decrease) in InventoriesUSD————-168,295
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-80,315
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-1,555,441
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Increase (Decrease) in Accounts PayableUSD————287,035
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-499,570
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-646,886
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Deferred Income Tax Expense (Benefit)USD————-22,065
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

36,329
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

89,603
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Net Cash Provided by (Used in) Operating ActivitiesUSD————2,903,584
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-1,207,305
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

3,106,403
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Cash flows from investing activities:
Payments to Acquire Businesses, Net of Cash AcquiredUSD————500,000
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

——
Net Cash Provided by (Used in) Investing ActivitiesUSD————-10,791,736
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-9,514,007
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-7,730,248
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Payments to Acquire Property, Plant, and EquipmentUSD————6,629,800
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

144,949
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

113,937
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Cash flows from financing activities:
Net Cash Provided by (Used in) Financing ActivitiesUSD————7,353,245
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

11,654,357
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

6,910,619
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD————-674,549
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

1,206,671
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

2,136,876
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD11,131,890
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2025-03-31

8,874,902
Source

6-K · 2025-08-20 · 0001213900-25-079036

As of 2024-03-31

8,684,188
Source

6-K · 2024-07-26 · 0001013762-24-001595

As of 2023-03-31

3,642,055
Source

6-K · 2023-08-23 · 0001213900-23-070295

As of 2022-03-31

7,461,630
Source

20-F · 2026-02-10 · 0001213900-26-013870

As of 2025-09-30

8,136,179
Source

20-F · 2025-01-24 · 0001213900-25-006519

As of 2024-09-30

6,929,508
Source

20-F · 2024-04-26 · 0001213900-24-036700

As of 2023-09-30

Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD————411,068
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

239,369
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

142,730
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Income Taxes Paid, NetUSD————564,795
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

205,373
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD————-139,642
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

273,626
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Additional Financial Items
AmortizationUSD————25,996
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

17,910
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

4,951
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Deferred Other Tax Expense (Benefit)USD——————89,602
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

DepreciationUSD————217,407
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

219,913
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

220,951
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Foreign Currency Transaction Gain (Loss), before TaxUSD————23,071
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-26,774
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-50,406
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Gain (Loss) on Sale of InvestmentsUSD————47,500
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

45,000
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Gain (Loss) on Disposition of Property Plant EquipmentUSD————-36,694
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-2,586
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

6,856
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

General and Administrative ExpenseUSD————2,533,438
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,261,752
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

1,921,367
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Income Tax Expense (Benefit)USD————214,572
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

763,879
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

343,707
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Investment Income, InterestUSD————789,070
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

466,524
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Net Income (Loss) Attributable to ParentUSD————1,191,297
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,675,927
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

2,878,230
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Net Income (Loss) Attributable to Noncontrolling InterestUSD————189,948
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-256,092
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Nonoperating Income (Expense)USD————987,635
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

544,966
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Operating ExpensesUSD————5,436,351
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

5,864,021
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

3,917,572
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Operating Lease, ExpenseUSD————193,379
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

201,176
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Other Operating Income (Expense), NetUSD——————354,675
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Proceeds from Issuance of Common StockUSD—————311,995
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Proceeds from Stock Options ExercisedUSD——————336,638
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025FY 2024FY 2023
Total RevenueUSD20,687,274
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

23,502,010
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

19,821,457
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Cost of RevenueUSD14,444,482
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

13,892,161
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

13,036,623
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Operating Income (Loss)USD608,182
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,638,748
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

2,867,262
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD1,595,817
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

4,183,714
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

3,221,937
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Income Tax Expense (Benefit)USD214,572
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

763,879
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

343,707
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Net Income (Loss) Attributable to Noncontrolling InterestUSD189,948
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-256,092
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Net Income (Loss) Attributable to ParentUSD1,191,297
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,675,927
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

2,878,230
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Earnings Per Share, BasicUSD per share0.01
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

0.02
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

0.02
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Earnings Per Share, DilutedUSD per share0.01
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

0.02
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

0.02
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Weighted Average Number of Shares Outstanding, Basicshares156,547,100
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

156,474,149
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

145,136,980
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Weighted Average Number of Shares Outstanding, Dilutedshares156,547,100
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

156,474,149
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

145,598,860
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Additional Financial Items
Foreign Currency Transaction Gain (Loss), before TaxUSD23,071
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

-26,774
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

-50,406
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

General and Administrative ExpenseUSD2,533,438
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

3,261,752
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

1,921,367
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Gross ProfitUSD6,044,533
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

9,502,769
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

6,784,834
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Interest Income (Expense), NetUSD——182,682
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Interest Income, OperatingUSD878,652
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

678,411
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Interest Income, OtherUSD——117,213
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Investment Income, InterestUSD789,070
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

466,524
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Nonoperating Income (Expense)USD987,635
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

544,966
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Operating ExpensesUSD5,436,351
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

5,864,021
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

3,917,572
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Operating Lease, ExpenseUSD193,379
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

201,176
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

—
Other Cost of Operating RevenueUSD——12,856,556
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Other IncomeUSD——222,399
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Other Operating Income (Expense), NetUSD——354,675
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Research and Development ExpenseUSD1,557,703
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

1,497,325
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

1,542,894
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Revenue Not from Contract with Customer, OtherUSD——1,022,358
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Selling ExpenseUSD1,345,210
Source

20-F · 2026-02-10 · 0001213900-26-013870

2024-10-01 to 2025-09-30

1,104,944
Source

20-F · 2025-01-24 · 0001213900-25-006519

2023-10-01 to 2024-09-30

453,311
Source

20-F · 2024-04-26 · 0001213900-24-036700

2022-10-01 to 2023-09-30

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-300203

F-3ASR · 2026-11-20 · 0001213900-26-122791

Terms from the governing filing for this registration; not a claim that the offering is open today.

Filing attachments

ea031216601ex4-1.htm · F-3ASR · 2026-11-20

Exhibit 4.1 DESCRIPTION OF SECURITIES General We are a Cayman Islands exempted company, and our corporate affairs are governed by our memorandum and articles of association, as amended from time to time (the “Memorandum and Articles”), the Companies Act (Revised) of the Cayman Islands (the “Companies Act”), and the common law of the Cayman Islands. The class A ordinary shares of a par value of US$0.001 each (the “Class A Ordinary Shares”) of JIN MEDICAL INTERNATIONAL LTD. (“we,” “our,” “our …

F-3ASR · 2026-11-20 · 0001213900-26-122791

Read attachment ↗
jinex99-1.htm · SCHEDULE 13G · 2026-08-18

Exhibit 99.1 JOINT FILING AGREEMENT In accordance with Rule 13G-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class A ordinary shares, par value of US$0.001 per share, of JIN MEDICAL INTERNATIONAL LTD., a Cayman Island…

SCHEDULE 13G · 2026-08-18 · 0001185185-26-003602

Read attachment ↗
ea029962601ex99-1.htm · 6-K · 2026-08-04

Exhibit 99.1 JIN MEDICAL INTERNATIONAL LTD. INDEX TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS TABLE OF CONTENTS CONTENTS PAGE(S) UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS AS OF MARCH 31, 2026 AND SEPTEMBER 30, 2025 F-2 UNAUDITED CONDENSED CONSOLIDATED STAT…

6-K · 2026-08-04 · 0001213900-26-085283

Read attachment ↗
ea029962601ex99-2.htm · 6-K · 2026-08-04

Exhibit 99.2 JIN MEDICAL INTERNATIONAL LTD. Reports First Half of Fiscal Year 2026 Financial Results CHANGZHOU, China, August 4, 2026 /PRNewswire/ -- JIN MEDICAL INTERNATIONAL LTD. (Nasdaq: ZJYL) (“Jin Medical”, and together with all its subsidiaries and consolidated entities, the “Company”), a NASDAQ-listed leading provider of rehabilitation medical equipment in China, today announced its unaudited financial results for the six months ended March 31, 2026. Mr. Erqi Wang, Chairman of the Boar…

6-K · 2026-08-04 · 0001213900-26-085283

Read attachment ↗
ea029619202ex99-1.htm · 6-K/A · 2026-06-30

Exhibit 99.1 JIN MEDICAL INTERNATIONAL LTD. No. 33 Lingxiang Road, Wujin District Changzhou City, Jiangsu Province People’s Republic of China NOTICE OF A MEETING OF THE HOLDERS OF CLASS A ORDINARY SHARES To Be Held at 9:00 p.m. Beijing Time on July 20, 2026 (9:00 a.m. Eastern Time on July 20, 2026) (Record Date  -  June 26, 2026) NOTICE OF A MEETING OF THE HOLDERS OF CLASS B ORDINARY SHARES To Be Held Immediately Following the Meeting of the Holders of the Class A Ordinary Shares NOTICE O…

6-K/A · 2026-06-30 · 0001213900-26-073727

Read attachment ↗
ea029619202ex99-2.htm · 6-K/A · 2026-06-30

Exhibit 99.2 Intentionally Omitted

6-K/A · 2026-06-30 · 0001213900-26-073727

Read attachment ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.